coronaviru
diseas
viral
respiratori
ill
caus
novel
coronaviru
origin
bat
singlestrand
rna
viru
name
world
health
organ
sever
acut
respiratori
syndrom
coronaviru
similar
viru
caus
sever
acut
respiratori
syndrom
infect
outbreak
began
decemb
wuhan
china
rapidli
spread
throughout
world
includ
brazil
march
th
declar
global
pandem
one
million
confirm
case
covid
report
includ
death
brazil
april
th
confirm
infect
patient
death
number
continu
increas
transmit
mainli
respiratori
droplet
aerosol
conjunctiva
clinic
spectrum
adult
rang
asymptomat
infect
sever
pneumonia
fatal
ill
main
clinic
symptom
includ
fever
cough
short
breath
myalgia
patient
develop
acut
respiratori
distress
syndrom
day
ill
base
data
patient
china
patient
mildli
affect
sever
manifest
critic
ill
death
occur
children
younger
year
mortal
rate
rang
age
older
year
risk
factor
sever
ill
older
age
preexist
comorbid
condit
includ
cardiovascular
diseas
hypertens
diabet
chronic
respiratori
diseas
cancer
children
age
appear
suscept
clinic
manifest
less
sever
compar
seen
adult
around
children
suffer
sever
diseas
lifethreaten
condit
patient
commonli
prior
histori
congenit
acquir
diseas
younger
year
digest
symptom
report
nearli
half
patient
diarrhea
fever
may
present
addit
respiratori
symptom
sinc
rna
detect
stool
sampl
clinic
specimen
awar
rais
regard
manag
patient
preexist
digest
diseas
inflammatori
bowel
diseas
ibd
special
attent
also
given
potenti
transmiss
via
fecal
rout
follow
viral
infect
virusspecif
rna
protein
synthes
cytoplasm
assembl
new
virion
detect
viral
rna
fece
day
neg
respiratori
sampl
suggest
virus
continu
secret
infect
gastrointestin
cell
period
viral
secret
pediatr
fece
longer
adult
observ
suggest
inflam
gut
adult
children
ibd
could
suscept
infect
doorway
viru
outbreak
rapidli
evolv
ibd
specialist
world
challeng
face
pandem
address
specif
issu
patient
particularli
regard
risk
infect
immunosuppress
treatment
review
aim
summar
best
avail
evid
expert
opinion
field
ibd
outbreak
risk
ibd
popul
ibd
treatment
often
involv
prescript
immunosuppress
ibd
patient
like
suscept
infect
depend
medic
use
outbreak
becam
rapidli
spread
pandem
sever
center
around
world
rais
concern
immunocompromis
patient
may
increas
risk
develop
infect
sever
respiratori
diseas
gener
ibd
patient
take
immunomodul
may
suscept
infect
especi
combin
biolog
mainli
antitnf
agent
addit
malnutrit
comorbid
older
age
previou
histori
seriou
infect
underli
ibd
activ
may
also
risk
factor
infect
previou
studi
demonstr
clinic
activ
ibd
exposur
thiopurin
increas
risk
viral
infect
howev
unlik
virus
influenza
herp
cytomegaloviru
adenoviru
rhinoviru
noroviru
respiratori
syncyti
viru
coronavirus
shown
caus
sever
diseas
immunosuppress
patient
far
intern
consensu
patient
ibd
greater
risk
infect
gener
popul
although
uncertain
whether
activ
inflamm
increas
risk
get
also
uncertain
ibd
patient
infect
higher
risk
develop
higher
rate
complic
mortal
result
diseas
although
data
regard
immunosuppress
patient
infect
scarc
guan
et
al
observ
use
immunomodul
risk
factor
seriou
diseas
patient
china
april
death
male
report
among
patient
ibd
intern
surveil
epidemiolog
coronaviru
research
exclus
secur
ibd
databas
three
patient
younger
year
old
receiv
treatment
one
immunosuppress
steroid
jak
inhibitor
adalimumabmethotrex
adalimumab
azathioprinesteroid
nevertheless
case
interpret
caution
sinc
mani
case
mild
diseas
test
coordin
initi
british
societi
gastroenterolog
bsg
crohn
coliti
uk
associ
specif
guidanc
provid
ibd
patient
accord
risk
depend
medic
use
age
risk
factor
decis
tree
patient
stratifi
accord
highest
moder
lowest
risk
seriou
complic
patient
highest
risk
either
comorbid
respiratori
cardiac
hypertens
diabet
mellitu
year
old
immunosuppress
therapi
ibd
age
receiv
mg
prednisolon
new
induct
therapi
biolog
immunomodul
combin
therapi
within
week
moder
sever
activ
diseas
short
gut
syndrom
patient
requir
parenter
nutrit
patient
receiv
biolog
therapi
thiopurin
calcineurin
inhibitor
jak
inhibitor
combin
therapi
stratifi
moder
risk
remain
ibd
patient
lowest
risk
patient
highest
risk
requir
selfisol
patient
moder
lowest
risk
follow
strict
gener
populac
social
distanc
respect
center
follow
bsg
recommend
regard
risk
stratif
although
also
consid
patient
subject
ibd
surgic
procedur
within
day
highest
risk
seriou
complic
brief
summari
specif
recommend
provid
us
patient
accord
risk
describ
tabl
past
month
emerg
evid
guid
optim
approach
prevent
coronaviru
infect
ibd
patient
assur
safeti
ongo
treatment
similar
gener
popul
ibd
patient
advis
stay
home
maintain
proper
distanc
talk
wash
hand
soap
alcoholbas
sanit
avoid
touch
facial
mucosa
tabl
institut
largest
latin
america
implement
massiv
structur
plan
evacu
ward
equip
intens
care
unit
provid
suffici
bed
patient
diagnos
infect
institut
rearrang
challeng
ibd
team
specif
approach
maintain
ibd
care
pandem
need
summari
measur
set
adapt
ibd
care
describ
tabl
gastroenterolog
depart
hospit
ibd
patient
realloc
isol
build
special
medic
staff
minim
exposur
viru
outpati
clinic
great
major
appoint
reschedul
although
formal
telehealth
system
avail
medic
staff
close
monitor
patient
sever
activ
diseas
requir
corticosteroid
treat
combin
therapi
via
telephon
call
moment
laboratori
test
strictli
limit
endoscopi
unit
attend
urgent
case
accord
recommend
guidelin
therefor
whenev
deem
necessari
ileocolonoscopi
replac
fecal
calprotectin
infus
center
staff
request
us
select
patient
could
infus
postpon
week
order
make
space
avail
rearrang
seat
use
patient
deep
clinic
endoscop
remiss
last
outpati
clinic
assess
main
criteria
reschedul
infus
cours
infus
distanc
approxim
seat
consid
safe
accompani
person
permit
although
acknowledg
use
surgic
mask
immunodefici
patient
indic
alway
avail
thu
screen
protocol
object
interview
implement
prior
admiss
systemat
assess
acut
respiratori
tract
symptom
cough
dyspnea
fever
among
ibd
patient
contact
asymptomat
patient
receiv
iv
infus
plan
highli
suspici
coronaviru
infect
refer
emerg
room
case
initi
biolog
extrem
necessari
feasibl
prefer
biolog
could
offer
subcutan
home
instead
intraven
would
requir
infus
center
recommend
associ
malnourish
risk
infect
well
describ
ibd
literatur
hypoalbuminemia
consid
system
inflammatori
marker
present
onefifth
ibd
patient
present
context
pandem
social
isol
could
neg
impact
patient
access
healthi
food
dietari
habit
result
ensu
nutrit
deficit
thu
recommend
balanc
diet
four
six
small
meal
day
adequ
hydrat
patient
also
encourag
quit
smoke
addit
ibd
patient
advis
updat
gener
immun
schedul
particularli
influenza
vaccin
routin
recommend
european
crohn
coliti
organ
ecco
guidelin
sever
studi
examin
role
vitamin
supplement
control
viral
replic
despit
lack
random
control
trial
scenario
kept
ibd
patient
vitamin
iron
replac
irondefici
anemia
detect
present
time
seem
appropri
recommend
discontinu
immunosuppress
treatment
patient
ibd
risk
reactiv
diseas
patient
stop
treatment
activ
inflamm
associ
increas
risk
hospit
surgeri
infect
exposur
steroid
avoid
context
use
nonhormon
antiinflammatori
drug
contraind
associ
advers
outcom
viral
respiratori
infect
potenti
role
trigger
reactiv
ibd
approv
children
evid
increas
risk
infect
monotherapi
advis
gener
good
safeti
profil
stop
develop
sign
symptom
suggest
approv
children
evid
increas
risk
infect
howev
tend
inhibit
immun
respons
viral
infect
initi
advis
maintain
therapi
without
increas
dose
stop
develop
sign
symptom
suggest
approv
children
patient
go
start
biolog
therapi
subcutan
rout
may
prefer
occas
avoid
visit
clinic
hospit
stop
therapi
shortterm
benefit
agent
take
month
clear
immunosuppress
effect
z
biolog
plu
immunomodul
stabl
patient
may
increas
risk
monotherapi
specif
evid
infus
facil
date
formal
evidencebas
recommend
clinic
societi
govern
immunosuppress
patient
like
ibd
tabl
summar
therapyspecif
consider
ibd
patient
base
mainli
expert
opinion
must
interpret
patientspecif
context
recommend
modifi
updat
new
evid
emerg
gener
patient
moder
sever
activ
crohn
diseas
ulcer
coliti
treat
therapi
would
chosen
regardless
pandem
asymptomat
ibd
patient
test
posit
whose
treatment
discontinu
ibd
drug
restart
day
assum
develop
case
occurr
sign
symptom
suggest
patient
must
immedi
commun
healthcar
team
context
recommend
paus
immunosuppress
therapi
infect
resolv
therapi
resum
complet
resolut
symptom
ideal
two
neg
pcr
test
nasopharyng
swab
collect
interv
strategi
current
feasibl
brazil
shortag
test
coronaviru
novel
coronaviru
creat
new
dilemma
surgeon
worldwid
mani
patient
await
surgeri
risk
develop
sever
pulmonari
infect
prolong
hospit
concern
particularli
critic
ibd
patient
immunosuppress
natur
diseas
commonli
use
medic
addit
nutrit
deficit
surgic
care
context
may
add
addit
morbid
main
goal
moment
ensur
safeti
patient
health
care
worker
current
recommend
base
larg
expert
opinion
may
chang
rapidli
outbreak
expect
escal
next
week
recent
report
wuhan
china
describ
outcom
patient
underw
elect
surgic
procedur
incub
period
earli
phase
outbreak
patient
develop
pneumonia
shortli
surgeri
patient
requir
admiss
intens
care
unit
seven
patient
die
therefor
highli
recommend
surgic
societi
around
world
postpon
elect
surgeri
endoscop
procedur
aim
protect
patient
surgeon
also
minim
use
necessari
resourc
hospit
bed
person
protect
equip
ppe
regard
surgic
procedur
concern
aerosol
viru
minim
invas
procedur
although
robust
evid
could
also
case
electrocauteri
use
open
surgeri
strict
use
ppe
accord
local
practic
advis
includ
mask
face
shield
protect
neg
pressur
surgic
room
use
avail
laparoscop
surgeri
smoke
evacu
system
advis
addit
essenti
staff
take
part
surgeri
embark
upon
oper
room
differ
aspect
consid
risk
infect
facil
expect
length
stay
possibl
surgic
complic
clinic
comorbid
may
add
addit
morbiditymort
surgic
treatment
deem
necessari
inform
consent
obtain
address
risk
infect
ideal
surgic
patient
test
preoper
although
strategi
possibl
institut
symptomat
patient
test
precis
advic
regard
ibd
patient
would
like
benefit
surgeri
context
sinc
ibd
societi
around
world
specif
address
surgic
care
therefor
medic
judgment
remain
essenti
group
consid
patient
anorect
septic
complic
ie
perian
abscess
due
crohn
diseas
acut
periton
bowel
obstruct
severetox
coliti
toxic
megacolon
gastrointestin
hemorrhag
fail
conserv
treatment
possibl
surgic
candid
pandem
case
analyz
individu
basi
advanc
colorect
malign
may
progress
unresect
diseas
also
consid
surgeri
avail
minim
invas
strategi
percutan
drainag
abscess
may
good
strategi
ibd
children
often
present
extens
sever
diseas
adult
therefor
infect
digest
symptom
particular
concern
pediatr
ibd
pibd
patient
april
rd
eleven
children
younger
year
report
infect
secureibd
total
patient
case
brazil
one
patient
younger
year
case
outpati
death
report
question
aros
pibd
patient
increas
risk
infect
infect
pibd
sever
adult
treatment
delay
discontinu
infect
recent
paper
pediatr
ibd
porto
group
espghan
outlin
key
inform
children
ibd
infect
provid
clear
guidanc
proceed
chines
korean
pediatr
gi
specialist
report
case
children
ibd
infect
pandem
european
report
pibd
patient
year
portoibd
group
secureibd
databas
chines
experi
report
children
confirm
infect
none
diagnosi
ibd
korea
children
confirm
diagnosi
ibd
almost
continu
ibd
treatment
among
children
postpon
biolog
infus
experienc
ibd
flare
europ
total
eight
patient
seven
portoibd
one
adolesc
year
secureibd
databas
major
crohn
diseas
patient
deep
remiss
moder
diseas
activ
index
one
cardiovascular
diseas
almost
patient
confirm
diagnosi
mild
symptom
fever
cough
fatigu
interestingli
none
eight
patient
diarrhea
initi
global
experi
may
help
mani
pibd
center
world
implement
action
pandem
nevertheless
mani
question
children
pibd
infect
remain
unansw
main
recommend
pertain
treatment
pibd
pandem
list
tabl
current
pandem
search
safeti
inform
guidanc
critic
ibd
patient
potenti
higher
risk
complic
due
chronic
ill
mainli
use
immunosuppress
treatment
face
challeng
circumst
group
adapt
ibd
care
reset
prioriti
provid
appropri
inform
patient
assur
continu
treatment
final
paramount
import
rememb
develop
countri
signific
part
popul
live
precari
condit
crowd
slum
dwell
lack
basic
sanit
among
uniqu
featur
deserv
special
attent
health
author
effect
adapt
turn
scenario
especi
case
ibd
patient
treatment
individu
mandatori
benefit
disadvantag
alway
taken
account
